Urine-based Cancer Risk Test 'misignal®' Launches in 24 Bic Camera Stores Nationwide, a First for Electronics Retailers

Bio-AI startup Craif Inc. has launched its urine-based cancer risk test 'misignal' in 24 Bic Camera stores and its online platform starting June 1, 2026, marking the first such partnership in the electronics retail sector.
businessNQ 54/100出典:PR Times

📋 Article Processing Timeline

  • 📰 Published: June 1, 2026 at 10:00
  • 🔍 Collected: June 1, 2026 at 10:26 (26 min after Published)
  • 🤖 AI Analyzed: June 1, 2026 at 19:09 (8h 43m after Collected)
Bio-AI startup Craif Inc. (CEO: Ryuichi Onose) has begun offering its urine-based cancer risk test, 'misignal,' at Bic Camera electronics stores operated by Bic Camera Inc. (President: Toru Akiho) as of June 1, 2026. This initiative marks the first time 'misignal' has been introduced in an electronics retail store. Two products, 'misignal scan' and 'misignal light,' are now available at 24 Bic Camera locations nationwide. Additionally, all four products in the 'misignal' series are available on the company's online shopping site, 'BicCamera.com,' to meet a wider range of needs. In recent years, electronics retailers have increasingly handled health appliances and healthcare-related products, serving as touchpoints for consumers to focus on their health in daily life. By deploying 'misignal' within this context, Craif aims to create opportunities for a new customer segment to learn about urine-based cancer risk testing. Furthermore, availability on BicCamera.com ensures that those unable to visit physical stores can easily access cancer risk testing from the comfort of their homes. Craif remains committed to delivering opportunities for early cancer detection to more people through diverse sales channels.

FAQ

Is this model applicable to the Taiwanese market?

Yes, major Taiwanese electronics retailers like Tsann Kuen could potentially integrate preventive health services to capture the aging population market.